This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

National Research Corporation Becomes Certified For ACO CAHPS

LINCOLN, Neb., Oct. 24, 2013 (GLOBE NEWSWIRE) -- As part of the Patient Protection and Affordable Care Act, National Research Corporation is pleased to announce its approval by the Centers for Medicaid and Medicare Services (CMS) as a CAHPS® survey provider for Accountable Care Organizations (ACOs). The approval is contingent upon successful completion of CMS training, which will be completed in October. CMS created three programs for ACOs through its Innovation Center (Pioneer ACO Model, Medicare Shared Savings Program, and Advance Payment ACO Model) and all are intended to reduce healthcare costs. The three programs are required to participate in quality measures, including the ACO CAHPS survey. ACOs are responsible for contracting with an approved vendor, such as National Research, to administer the survey beginning in 2014. ACOs are groups of doctors, hospitals, and other healthcare providers, who come together voluntarily to give coordinated, high-quality care to Medicare patients. The ACO CAHPS survey measures the patient experience for accountable care organizations and also assesses specific measures included in the Medicare Shared Savings Program and Pioneer ACO Model. In addition, National Research announces its certification for the Medicare Advantage – Prescription Drug Plan (MA-PDP) CAHPS Survey. This survey is an initiative to assess patient experience among beneficiaries of Medicare Advantage plans. CMS requires all MA and PDP contracts with more than 600 enrollees to contract with an approved vendor. National Research will also begin surveying MA-PDP CAHPS next year. "We are very excited to continue offering new CAHPS surveys that meet the evolving needs of the healthcare profession," said Susan L. Henricks, president and chief operating officer at National Research. "It's important we help the efforts of accountable care organizations to support delivering high-quality, patient-centered care." About National Research Corporation

For more than 30 years, National Research Corporation (NASDAQ: NRCIA and NRCIB) has been at the forefront of patient-centered care. Today, the company's focus on empowering customer-centric healthcare across the continuum extends patient-centered care to incorporate families, communities, employees, senior housing residents, and other stakeholders. Recognized by Modern Healthcare as one of the largest patient satisfaction firms in the U.S., National Research is dedicated to representing the true voice of patients and other healthcare stakeholders. This integration of cross-continuum metrics and analytics uncovers insights for effective performance improvement, quality measurement, care transitions, and many other factors that impact population health management. National Research is headquartered in Lincoln, Nebraska. For more information, call 800-388-4264, write to, or visit .
CONTACT: Scott Smith
         Director of Marketing
         National Research Corporation

National Research Corporation Logo

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $94.22 -1.00%
FB $118.14 0.60%
GOOG $699.02 0.96%
YHOO $35.79 -0.61%
TSLA $228.74 -1.50%


Chart of I:DJI
DOW 17,667.22 -83.69 -0.47%
S&P 500 2,050.46 -12.91 -0.63%
NASDAQ 4,728.6950 -34.5290 -0.72%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs